Other pharmacological drugs that improve HF survival by targeting endothelial function include ACE inhibitors, β-blockers, type 5 phosphodiesterase (PDE5) inhibitors, and soluble guanylate cyclase (sGC) activators. The gene discussed is SGCB; the disease is hydrops fetalis.